Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Genmab announces positive top-line Phase II results of ofatumumab in multiple sclerosis
National Cancer Institute Search for Clinical Trials
Trimesta in relapsing-remitting multiple sclerosis patients (Phase II)
Biogen Reports Another Tecfidera PML Case
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.
Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
Generic interferon-beta
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Pathological mechanisms in progressive multiple sclerosis.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Thrombotic microangiopathy associated with interferon beta.
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.

Pages